Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation (NASDAQ:TELA)
Earnings Call Insights: TELA Bio, Inc. (TELA) Q4 2025 Management View Antony Koblish, Co-founder, CEO & Director, highlighted that 2025, ...
Thursday, May 21, 2026
Tag: BIO
Boundless Bio Inc (BOLD) Q4 2025 Earnings Results
Earnings Per Share (GAAP) $-0.58 estimate N/A Revenue $17.3M estimate N/A Loss narrows sequentially. Boundless Bio Inc reported a loss ...
UK’s AstraZeneca completes acquisition of SixPeaks Bio to advance next-gen obesity treatments
AstraZeneca finalises buyout of SixPeaks Bio to accelerate advanced obesity treatment pipeline. Get access to the full article? Become our ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.